Categories: News

Sanofi: Information concerning the total number of voting rights and shares – October 2024

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)

        

Sanofi
a French société anonyme with a registered share capital of 2,537,214,304 €
Registered office : 46, avenue de la Grande Armée – 75017 Paris – France
Registered at the Paris Commercial and Companies Registry under number 395 030 844

Date

Total number of
issued shares

Number of real
voting rights
(excluding treasury shares)
Theoretical number of
voting rights
(including treasury shares)*
October 31, 2024 1,268,922,721 1,413,229,859 1,428,560,940

* Pursuant to article 223-11 of the Règlement général de l’Autorité des Marchés Financiers.

This information is also available on the internet website of sanofi under « Regulated Information in France »:
https://www.sanofi.com/en/investors/sanofi-share-and-adrs/share-overview/shares-and-voting-rights/

Investor Relations Department
e-mail: investor.relations@sanofi.com

Attachment

Staff

Recent Posts

MaryRuth’s Celebrates TikTok Shop Super Brand Day With Exclusive Offers and Viral Favorites

LOS ANGELES, Jan. 12, 2025 /PRNewswire/ -- MaryRuth's, the trusted leader in liquid vitamins and…

3 hours ago

Lipozem: Introducing Lipozem as the Bizarre Turmeric Hack for Weight Loss Support

LAKELAND, Fla., Jan. 12, 2025 (GLOBE NEWSWIRE) -- Lipozem emerges in an era where weight…

6 hours ago

AI Wellness Launches SoCal Fire Relief Initiative to Support Families and First Responders in Southern California

LOS ANGELES, Jan. 11, 2025 /PRNewswire/ -- Demonstrating a commitment to both innovation and compassion,…

15 hours ago

Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced…

1 day ago

Matinas BioPharma Receives NYSE Noncompliance Notice

BEDMINSTER, N.J. , Jan. 10, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American:…

1 day ago